Holen Sie sich die Stockscreener-App
1.16
4.50%
0.05
Vorhandelsmarkt:
1.16
Schlusskurs vom Vortag:
$1.11
Offen:
$1.13
24-Stunden-Volumen:
1.50M
Relative Volume:
4.06
Marktkapitalisierung:
$5.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.07M
KGV:
-0.0829
EPS:
-13.99
Netto-Cashflow:
$-12.56M
1W Leistung:
+54.63%
1M Leistung:
+59.85%
6M Leistung:
-23.68%
1J Leistung:
-71.98%
1-Tages-Spanne:
$1.1201
$1.29
1-Wochen-Bereich:
$0.7647
$1.29
52-Wochen-Spanne:
$0.60
$4.65
Palisade Bio Inc Stock (PALI) Company Profile
Firmenname
Palisade Bio Inc
Sektor
Branche
Telefon
(858) 704-4900
Adresse
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Vergleichen Sie PALI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.16 | 5.55M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc Aktie (PALI) Neueste Nachrichten
When is the best time to buy Palisade Bio Inc. stock2-Day Signal Watch with Forecast Outcome - Newser
How sentiment analysis helps forecast Palisade Bio Inc. Trend Analysis for Safer Market Entries - Newser
How does Palisade Bio Inc. compare to its industry peersExplosive earning power - jammulinksnews.com
Is Palisade Bio Inc. a growth stock or a value stockDiscover high-impact stocks for growth - jammulinksnews.com
What institutional investors are buying Palisade Bio Inc. stockAccelerated wealth building - jammulinksnews.com
What markets is Palisade Bio Inc. expanding into Is MLACU stock a good long term investment optionFree Predictions - jammulinksnews.com
Is Palisade Bio Inc. Stock a Good Fit for Conservative InvestorsFree Stock Investment Discussion Area - Newser
How Palisade Bio Inc. stock performs during market volatility5x Profit Potential - Newser
Should I hold or sell Palisade Bio Inc. stock in 2025Unlock hidden market opportunities today - jammulinksnews.com
Palisade Bio Inc. Stock Analysis and ForecastHigh-profit capital plays - PrintWeekIndia
What analysts say about Palisade Bio Inc. stockSkyrocketing investment returns - PrintWeekIndia
Palisade Bio Enters Warrant Inducement Agreement - TipRanks
What makes Palisade Bio Inc. stock price move sharplyFree Join Group - Newser
What institutions are buying Palisade Bio Inc. stock nowFree Stock Selection - jammulinksnews.com
Palisade Bio Plunges 11.48% Despite Positive Trial Results - AInvest
What drives Palisade Bio Inc. stock priceBreakthrough financial growth - Autocar Professional
Palisade Bio Secures $3.9M Cash Injection: Strategic Warrant Exercise Deal Includes New 5-Year Warrants - Stock Titan
Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million - GlobeNewswire
Palisade Bio Skyrockets 16.28%—Can This Biotech Cinderella Story Sustain Its Magic? - AInvest
Is Palisade Bio Inc. a good long term investmentRecord-breaking gains - jammulinksnews.com
Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference - GlobeNewswire
Palisade Bio Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times
Palisade Bio Surges 22.6% on Unseen Catalyst: What’s Fueling the Momentum? - AInvest
Why Palisade Bio Inc. stock attracts strong analyst attentionBreakout Confirmation Tool - Newser
Palisade Bio appoints to its Board of Directors - MSN
Palisade Bio appoints Emil Chuang to board of directors By Investing.com - Investing.com Nigeria
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors - Santé log
Finanzdaten der Palisade Bio Inc-Aktie (PALI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Palisade Bio Inc-Aktie (PALI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wei Binxian | Director |
Nov 21 '24 |
Option Exercise |
0.00 |
388 |
0 |
855 |
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):